BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 414184)

  • 1. [Theoretical and applied aspects of experimental teratology].
    Dyban AP
    Ontogenez; 1977; 8(6):582-98. PubMed ID: 414184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wilson's principles--a base of modern teratology].
    Burdan F; Bełzek A; Szumiło J; Dudka J; Korobowicz A; Tokarska E; Klepacz L; Bełzek M; Klepacz R
    Pol Merkur Lekarski; 2006 Mar; 20(117):358-61. PubMed ID: 16780275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of in vitro procedures in teratology.
    Kochhar DM
    Teratology; 1975 Jun; 11(3):273-87. PubMed ID: 125462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenesis.
    Harris JM; Pashayan HM
    Orthop Clin North Am; 1976 Apr; 7(2):281-9. PubMed ID: 1264426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental staging and thalidomide teratogenicity in the green monkey (Cercopithecus aethiops).
    Hendrickx AG; Sawyer RH
    Teratology; 1978 Dec; 18(3):393-404. PubMed ID: 105418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Teratology and epidemiology in the study of environmental teratogens].
    Cayré R; Sánchez-Gómez C; Moreno-Rodríguez RA; de la Cruz MV
    Bol Med Hosp Infant Mex; 1992 Jul; 49(7):397-403. PubMed ID: 1418645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryotoxicity and teratogenicity of thalidomide in rats.
    Parkhie M; Webb M
    Teratology; 1983 Jun; 27(3):327-32. PubMed ID: 6410529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigations on the effect of the combination sulfamoxole/trimethoprim on fertility and fetal development in rats and rabbits (author's tranls)].
    Helm F; Kretzschmar R; Leuschner F; Neumann W
    Arzneimittelforschung; 1976; 26(42):643-51. PubMed ID: 947325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of drugs on embryonic development.
    Netzloff ML
    Ann Clin Lab Sci; 1976; 6(4):332-41. PubMed ID: 962297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of teratogen-induced abnormal development in mouse and rat embryos in vitro.
    Kapron CM; Trasler DG
    Int J Dev Biol; 1997 Apr; 41(2):337-44. PubMed ID: 9184343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Teratogenic and embryotoxic activity of several 2,4-diaminopyrimidine derivatives].
    Dyban AP; Bariliak IR; Tikhodeeva II
    Arkh Anat Gistol Embriol; 1976 Jul; 71(7):29-33. PubMed ID: 999531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects of the teratology of cyclophosphamide (NSC-26271).
    Ashby R; Davis L; Dewhurst BB; Espinal R; Penn RN; Upshall DG
    Cancer Treat Rep; 1976 Apr; 60(4):477-82. PubMed ID: 1277224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Environmental and occupational factors in the development of congenital malformations].
    Marcickiewicz J; Chazan B; Troszyński M; Szmigielski S
    Probl Med Wieku Rozwoj; 1983; 12():190-202. PubMed ID: 6674973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats.
    Patil RD; Dwivedi P; Sharma AK
    Reprod Toxicol; 2006 Nov; 22(4):679-87. PubMed ID: 16781114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the developmental toxicity of lenalidomide in rabbits.
    Christian MS; Laskin OL; Sharper V; Hoberman A; Stirling DI; Latriano L
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):188-207. PubMed ID: 17570132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.